BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $441,000 | +11.9% | 6,699 | -14.2% | 0.17% | +21.7% |
| Q2 2022 | $394,000 | -20.6% | 7,809 | +0.5% | 0.14% | -10.4% |
| Q1 2022 | $496,000 | -41.0% | 7,769 | -0.9% | 0.15% | -30.0% |
| Q4 2021 | $840,000 | +5.1% | 7,839 | +0.9% | 0.22% | +0.9% |
| Q3 2021 | $799,000 | +14.1% | 7,769 | -2.4% | 0.22% | +10.1% |
| Q2 2021 | $700,000 | -14.7% | 7,959 | -5.7% | 0.20% | -21.4% |
| Q1 2021 | $821,000 | -6.2% | 8,439 | +8.2% | 0.25% | -8.4% |
| Q4 2020 | $875,000 | +21.7% | 7,799 | +0.5% | 0.28% | +4.2% |
| Q3 2020 | $719,000 | +36.4% | 7,759 | +14.8% | 0.26% | +26.3% |
| Q2 2020 | $527,000 | – | 6,760 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |